These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 37446350)

  • 1. Aprotinin-Drug against Respiratory Diseases.
    Ivachtchenko AV; Ivashchenko AA; Shkil DO; Ivashchenko IA
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aprotinin Inhibits SARS-CoV-2 Replication.
    Bojkova D; Bechtel M; McLaughlin KM; McGreig JE; Klann K; Bellinghausen C; Rohde G; Jonigk D; Braubach P; Ciesek S; Münch C; Wass MN; Michaelis M; Cinatl J
    Cells; 2020 Oct; 9(11):. PubMed ID: 33143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19.
    Redondo-Calvo FJ; Padín JF; Muñoz-Rodríguez JR; Serrano-Oviedo L; López-Juárez P; Porras Leal ML; González Gasca FJ; Rodríguez Martínez M; Pérez Serrano R; Sánchez Cadena A; Bejarano-Ramírez N; Muñoz Hornero C; Barberá Farré JR; Domínguez-Quesada I; Sepúlveda Berrocal MA; Villegas Fernández-Infantes MD; Manrique Romo MI; Parra Comino Á; Pérez-Ortiz JM; Gómez-Romero FJ;
    Eur J Clin Invest; 2022 Jun; 52(6):e13776. PubMed ID: 35342931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.
    Padín JF; Pérez-Ortiz JM; Redondo-Calvo FJ
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2.
    Ivashchenko AA; Zagribelnyy BA; Ivanenkov YA; Ivashchenko IA; Karapetian RN; Kravchenko DV; Savchuk NP; Yakubova EV; Ivachtchenko AV
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Aprotinin and Avifavir
    Ivashchenko AA; Azarova VN; Egorova AN; Karapetian RN; Kravchenko DV; Krivonos NV; Loginov VG; Poyarkov SV; Merkulova EA; Rosinkova OS; Savchuk NP; Topr MA; Simakina EN; Yakubova EV; Ivachtchenko AV
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34199134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction].
    Zhirnov OP; Klenk HD
    Vopr Virusol; 2011; 56(3):24-8. PubMed ID: 21786623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    Boon ACM; Bricker TL; Fritch EJ; Leist SR; Gully K; Baric RS; Graham RL; Troan BV; Mahoney M; Janetka JW
    J Virol; 2024 May; 98(5):e0190323. PubMed ID: 38593045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function.
    Padín JF; Pérez-Ortiz JM; Redondo-Calvo FJ
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo.
    Song EJ; Españo E; Shim SM; Nam JH; Kim J; Lee K; Park SK; Lee CK; Kim JK
    Sci Rep; 2021 May; 11(1):9427. PubMed ID: 33941825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
    Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus.
    Zhirnov OP; Matrosovich TY; Matrosovich MN; Klenk HD
    Antivir Chem Chemother; 2011 Mar; 21(4):169-74. PubMed ID: 21602614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favipiravir in SARS-CoV-2 Infection: Is it Worth it?
    Batiha GE; Moubarak M; Shaheen HM; Zakariya AM; Usman IM; Rauf A; Adhikari A; Dey A; Alexiou A; Hetta HF; Al-Gareeb AI; Al-Kuraishy HM
    Comb Chem High Throughput Screen; 2022; 25(14):2413-2428. PubMed ID: 35430987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses.
    Chianese A; Zannella C; Monti A; Doti N; Sanna G; Manzin A; De Filippis A; Galdiero M
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
    Bai X; Hippensteel J; Leavitt A; Maloney JP; Beckham D; Garcia C; Li Q; Freed BM; Ordway D; Sandhaus RA; Chan ED
    Med Hypotheses; 2021 Jan; 146():110394. PubMed ID: 33239231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery].
    Corbeau JJ; Monrigal JP; Jacob JP; Cottineau C; Moreau X; Bukowski JG; Subayi JB; Delhumeau A
    Ann Fr Anesth Reanim; 1995; 14(2):154-61. PubMed ID: 7486272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.